Synaptogenix, Inc., an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, announced that the Food & Drug...

Cartesian Therapeutics, Inc, a clinical─stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, announced that the first...

NEW YORK — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical stage biopharmaceutical...

CAMBRIDGE, Mass., June 26, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic...

MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing...

CDR─Life Inc, a global company developing powerful T─cell engagers (TCE) to eradicate hard─to─treat solid tumors, has announced an expansion...

PTC Therapeutics (PTCT) falls as the EC's advisory committee adopts a negative opinion regarding the renewal of the conditional marketing approval of...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Lupus Nephritis pipeline constitutes 20+ key companies continuously...

The human species is currently at an inflexion point. Can we mobilise the quantum of ingenuity needed to expand and advance our current capacity to...

The human species is currently at an inflexion point. Can we mobilise the quantum of ingenuity needed to expand and advance our current capacity to...